These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34006319)

  • 1. Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration.
    Modi A; Vaishnav KG; Kothiya K; Alexander N
    Infect Dis Poverty; 2021 May; 10(1):73. PubMed ID: 34006319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
    Mehta PK; Maharjan M
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010-2015.
    Dorkenoo MA; Bronzan R; Yehadji D; Tchalim M; Yakpa K; Etassoli S; Adjeloh P; Maman I; Sodahlon Y
    Parasit Vectors; 2018 Apr; 11(1):244. PubMed ID: 29661231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
    Modi A; Gamit S; Jesalpura BS; Kurien G; Kosambiya JK
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005476. PubMed ID: 28369129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
    Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
    Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
    Yokoly FN; Zahouli JBZ; Méite A; Opoku M; Kouassi BL; de Souza DK; Bockarie M; Koudou BG
    PLoS One; 2020; 15(4):e0231541. PubMed ID: 32282840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
    Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
    Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis.
    Burgert-Brucker CR; Zoerhoff KL; Headland M; Shoemaker EA; Stelmach R; Karim MJ; Batcho W; Bougouma C; Bougma R; Benjamin Didier B; Georges N; Marfo B; Lemoine JF; Pangaribuan HU; Wijayanti E; Coulibaly YI; Doumbia SS; Rimal P; Salissou AB; Bah Y; Mwingira U; Nshala A; Muheki E; Shott J; Yevstigneyeva V; Ndayishimye E; Baker M; Kraemer J; Brady M
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008301. PubMed ID: 32479495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
    Rao RU; Nagodavithana KC; Samarasekera SD; Wijegunawardana AD; Premakumara WD; Perera SN; Settinayake S; Miller JP; Weil GJ
    PLoS Negl Trop Dis; 2014; 8(11):e3281. PubMed ID: 25393404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.
    Bah YM; Paye J; Bah MS; Conteh A; Redwood-Sawyerr V; Sonnie M; Veinoglou A; Koroma JB; Hodges MH; Zhang Y
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008877. PubMed ID: 33370270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress on elimination of lymphatic filariasis in Sierra Leone.
    Koroma JB; Sesay S; Conteh A; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y
    Parasit Vectors; 2018 Jun; 11(1):334. PubMed ID: 29866207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration.
    de Souza DK; Ansumana R; Sessay S; Conteh A; Koudou B; Rebollo MP; Koroma J; Boakye DA; Bockarie MJ
    Parasit Vectors; 2015 Sep; 8():488. PubMed ID: 26399968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring migrant groups as a post-validation surveillance approach to contain the potential reemergence of lymphatic filariasis in Togo.
    Dorkenoo MA; Tchankoni MK; Yehadji D; Yakpa K; Tchalim M; Sossou E; Bronzan R; Ekouevi DK
    Parasit Vectors; 2021 Mar; 14(1):134. PubMed ID: 33653393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of 'transmission assessment surveys' (TAS) for the lymphatic filariasis elimination program.
    Dewi RM; Tuti S; Ganefa S; Anwar C; Larasati R; Ariyanti E; Herjati H; Brady M
    Parasit Vectors; 2015 Oct; 8():499. PubMed ID: 26427536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.